THW (Tekla World Healthcare Fund) Notes Receivable: $0.00 Mil (As of Mar. 2026)


THW Tekla World Healthcare Fund THW
57 GF Score
Price $13.49
GF Value $19.36
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is Tekla World Healthcare Fund Notes Receivable?

Tekla World Healthcare Fund THW -1.35% 57 Notes Receivable is $0.00 Mil as of Mar. 2026. GuruFocus rates THW with a GF Score™ of 57/100 and a GF Value™ of $19.36 (Significantly Undervalued). The stock has 6 warning signs investors should review.

Tekla World Healthcare Fund's Notes Receivable for the quarter that ended in Mar. 2026 was $0.00 Mil.

Tekla World Healthcare Fund Notes Receivable Related Terms

Tekla World Healthcare Fund Notes Receivable Historical Data

* Premium members only.

The historical data trend for Tekla World Healthcare Fund's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tekla World Healthcare Fund Notes Receivable Chart

Tekla World Healthcare Fund Annual Data
Trend Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Notes Receivable
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Tekla World Healthcare Fund Semi-Annual Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
THW
57GF Score
Tekla World Healthcare Fund THW
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tekla World Healthcare Fund Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.00 Mil mean?
Tekla World Healthcare Fund (THW) has a Notes Receivable of $0.00 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Tekla World Healthcare Fund and its competitors.
Is Tekla World Healthcare Fund's Notes Receivable too high?
Tekla World Healthcare Fund's current Notes Receivable is $0.00 Mil. Overall, Tekla World Healthcare Fund has a GF Score™ of 57/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tekla World Healthcare Fund's Notes Receivable compare to MSIF and IQI?
Tekla World Healthcare Fund's Notes Receivable of $0.00 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for an Asset Management company?
A good Notes Receivable depends on the Asset Management industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Tekla World Healthcare Fund and its competitors. Tekla World Healthcare Fund's current Notes Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tekla World Healthcare Fund stock overvalued right now?
Based on GuruFocus' analysis, Tekla World Healthcare Fund (THW) is currently considered Significantly Undervalued. The stock's GF Value™ is $19.36, compared to a current price of $13.49 — trading 30.3% below its estimated fair value. The current Notes Receivable is $0.00 Mil. Tekla World Healthcare Fund's overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Tekla World Healthcare Fund (THW), the current Notes Receivable is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tekla World Healthcare Fund (THW) Overvalued in 2026?

Based on GuruFocus' analysis, Tekla World Healthcare Fund stock appears to be undervalued. The current stock price of $13.49 is trading 30.3% below its estimated GF Value™ of $19.36. GuruFocus considers Tekla World Healthcare Fund to be Significantly Undervalued.

Key valuation signals for THW:

  • Notes Receivable: $0.00 Mil
  • GF Value™: $19.36 vs. price of $13.49 (30.3% below fair value)
  • GF Score™: 57/100 with 6 warning signs

No single metric tells the full story. See the THW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tekla World Healthcare Fund Business Description

Address 1900 Market Street, Suite 200, Philadelphia, PA, USA, 19103
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.
57GF Score

Get the complete analysis for THW

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.49
Price
$19.36
GF Value